Edward A. O’Neill
Merck & Co., Inc., Rahway, NJ, USA (United States) · 111 works · 6,253 citations · h-index 36
Top works
- The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain
- FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin
- Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF‐kappa B.
- Transcription Factor OTF-1 Is Functionally Identical to the DNA Replication Factor NF-III
- Sequence-Specific Interactions Between Cellular DNA-Binding Proteins and the Adenovirus origin of DNA Replication
- Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein Kinase
- Purification and characterization of nuclear factor III (origin recognition protein C), a sequence-specific DNA binding protein required for efficient initiation of adenovirus DNA replication.
- The Activation State of p38 Mitogen-Activated Protein Kinase Determines the Efficiency of ATP Competition for Pyridinylimidazole Inhibitor Binding
- The Effect of Sodium Salicylate and Aspirin on NF-κB
- A Novel FK506 Binding Protein Can Mediate the Immunosuppressive Effects of FK506 and Is Associated with the Cardiac Ryanodine Receptor
- Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes
- Pyrroles and other heterocycles as inhibitors of P38 kinase
- Overlapping octamer and TAATGARAT motifs in the VF65-response elements in herpes simplex virus immediate-early promoters represent independent binding sites for cellular nuclear factor III
- T cell responses in calcineurin A alpha-deficient mice.
- Kinetic Mechanism for p38 MAP Kinase
- Molecular Basis for p38 Protein Kinase Inhibitor Specificity
- Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double‐blind, non‐inferiority trial
- Regulation of IkB α phosphorylation by PKC- and Ca2+-dependent signal transduction pathways
- Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase
- Transposon Tn5 encodes streptomycin resistance in nonenteric bacteria